Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lecanemab in Alzheimer's Disease Through Multi-omics Approaches
NCT07604896Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of lecanemab in Alzheimer's disease (AD), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Started Jan 2026; status: recruiting.
02
Drugs
lecanemab
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT07604896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07604896.